BSESudarshan Pharma Industries Ltd· Chemicals & PetrochemicalsHighNegative
Announced Thu, 26 Feb, 2026 · 17:18 IST

In continuation to our letter dated February 22, 2026, we hereby inform you that GST inspection, search and seizure operation at the registered office of the Company which commenced on ....

Enforcement RaidRegulatory & Legal View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.3%Reaction day
₹27.50
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.1%+4.3% vs market
Specialty Chemicals peers, median of 88sector-0.7%+3.9% vs sector

On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 3.9 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+3.3-1.1+4.3-0.7+3.9
Next day
-3.1-3.3+0.2-3.3+0.3
2d
-5.7-5.8+0.1-5.0-0.7
3d
-9.1-4.9-4.2-4.4-4.6
4d
-8.0-4.9-3.1-5.0-3.1
5d
-8.5-7.5-1.0-6.4-2.1
1w
-9.5-5.4-4.1-5.2-4.2
15d
-20.2-11.7-8.5-11.1-9.1
1m
-10.9-9.6-1.3-10.7-0.2
2m
+10.0+7.2+2.8+3.4+6.6
3m
+32.9+10.5+22.4+7.8+25.1
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 88Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Goods & Service Tax Department, Mumbai conducted a search and inspection under Section 67 of the Maharashtra GST Act, 2017 at the company's registered office in Borivali West, Mumbai. The operation ran from February 21, 2026 to February 25, 2026, and the company fully co-operated throughout. The company clarified that no violations or contraventions were found against it — any liability relates to non-compliance by one of its vendors. There is no material impact on the company's financials, operations, or other activities.

Likely market impact

Positive for shareholders — the company has been cleared of any direct wrongdoing, and the issue is confined to a vendor's compliance lapse with no material financial or operational impact on Sudarshan Pharma.